Agnieszka Majkowska-Pilip

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 25

Top Topics

Raman Spectroscopy

Top Venues

Molecules (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Perihan Ünak, Volkan Yasakci, Elif Tutun, Kadriye Busra Karatay, Rafał Walczak, Kamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, Aleksander Bilewicz
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44 Sc and 47 Sc for Theranostic Application. Pharmaceutics 15 (3) (2023)
Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers. Molecules (Basel, Switzerland) 28 (6) (2023)
Kinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles. Molecular pharmaceutics (2023)
Kamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, Mateusz Wierzbicki, Aleksander Bilewicz
Platinum nanoparticles labelled with iodine-125 for combined "chemo-Auger electron" therapy of hepatocellular carcinoma. Nanoscale advances 5 (12) (2023)
Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers. Molecules (Basel, Switzerland) 28 (6) (2023)
Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers. Molecules (Basel, Switzerland) 28 (6) (2023)
Perihan Ünak, Volkan Yasakci, Elif Tutun, Kadriye Busra Karatay, Rafał Walczak, Kamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, Aleksander Bilewicz
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44 Sc and 47 Sc for Theranostic Application. Pharmaceutics 15 (3) (2023)
Perihan Ünak, Volkan Yasakci, Elif Tutun, Kadriye Busra Karatay, Rafał Walczak, Kamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, Aleksander Bilewicz
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44 Sc and 47 Sc for Theranostic Application. Pharmaceutics 15 (3) (2023)
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, Kinga Żelechowska-Matysiak, Ewelina Chajduk, Aleksander Bilewicz
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma. International journal of molecular sciences 23 (23) (2022)
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, Kinga Żelechowska-Matysiak, Ewelina Chajduk, Aleksander Bilewicz
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma. International journal of molecular sciences 23 (23) (2022)
Michał Żuk, Rafał Podgórski, Anna Ruszczyńska, Tomasz Ciach, Agnieszka Majkowska-Pilip, Aleksander Bilewicz, Paweł Krysinski
Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment. Pharmaceutics 14 (8) (2022)
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, Kinga Żelechowska-Matysiak, Ewelina Chajduk, Aleksander Bilewicz
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma. International journal of molecular sciences 23 (23) (2022)
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, Kinga Żelechowska-Matysiak, Ewelina Chajduk, Aleksander Bilewicz
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma. International journal of molecular sciences 23 (23) (2022)
Adrianna Cytryniak, Kinga Żelechowska-Matysiak, Ewa Nazaruk, Renata Bilewicz, Rafał Walczak, Emilia Majka, Adam Mames, Frank Bruchertseifer, Alfred Morgenstern, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter 213 Bi. Molecular pharmaceutics 19 (8) (2022)
Dorota Nieciecka, Joanna Celej, Michał Żuk, Agnieszka Majkowska-Pilip, Kinga Żelechowska-Matysiak, Antoni Lis, Magdalena Osial
Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin. Pharmaceutics 13 (4) (2021)
Michał Żuk, Weronika Gawęda, Agnieszka Majkowska-Pilip, Magdalena Osial, Marcin Wolski, Aleksander Bilewicz, Paweł Krysinski
Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy. Pharmaceutics 13 (11) (2021)
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Damian Gawel, Ewelina Chajduk, Tadeusz Pieńkowski, Aleksander Bilewicz
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy. Molecules (Basel, Switzerland) 26 (7) (2021)
Weronika Gawęda, Marek Pruszynski, Edyta Cędrowska, Magdalena Rodak, Agnieszka Majkowska-Pilip, Damian Gawel, Frank Bruchertseifer, Alfred Morgenstern, Aleksander Bilewicz
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials (Basel, Switzerland) 10 (10) (2020)
Malwina Czerwińska, Giulio Fracasso, Marek Pruszynski, Aleksander Bilewicz, Marcin K Kruszewski, Agnieszka Majkowska-Pilip, Anna Lankoff
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I. Materials (Basel, Switzerland) 13 (17) (2020)
Adrianna Cytryniak, Ewa Nazaruk, Renata Bilewicz, Emilia Górzyńska, Kinga Żelechowska-Matysiak, Rafał Walczak, Adam Mames, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with 177Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers. Nanomaterials (Basel, Switzerland) 10 (11) (2020)
Agnieszka Majkowska-Pilip, Weronika Gawęda, Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Aleksander Bilewicz
Nanoparticles in Targeted Alpha Therapy. Nanomaterials (Basel, Switzerland) 10 (7) (2020)
Łucja Dziawer, Agnieszka Majkowska-Pilip, Damian Gawel, Charlotte Gimpel, Marek Pruszynski, Jerzy Jastrzębski, Bogdan Wąs, Aleksander Bilewicz
Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer. Nanomaterials (Basel, Switzerland) 9 (4) (2019)
Agnieszka Majkowska-Pilip, Paweł Krzysztof Halik, Ewa Gniazdowska
The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy. Pharmaceutics 11 (9) (2019)
Monika Lyczko, Krzysztof Łyczko, Agnieszka Majkowska-Pilip, Aleksander Bilewicz
1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes-Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies. Molecules (Basel, Switzerland) 24 (21) (2019)
Agnieszka Majkowska-Pilip, Maria Rius, Frank Bruchertseifer, Christos Apostolidis, Mirjam Weis, Milton Bonelli, Marta Laurenza, Leszek Królicki, Alfred Morgenstern
In vitro evaluation of 225 Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme. Chemical biology & drug design 92 (1) (2018)